OCDX News and Press, Ortho Clinical Diagnostics plc From 02/16/22

Ortho Clinical Diagnostics press release (NASDAQ:OCDX): Q4 Non-GAAP EPS of $0.18 beats by $0.03. Revenue of $521M (+0.9% Y/Y) misses by $4.26M. For further details see: Ortho Clinical Diagnostics Non-GAAP EPS of $0.18 beats by $0.03, revenue of $521M misses by $4.26M

RARITAN, N.J., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the fourth quarter and fiscal year ended Ja...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Gainers: Alnylam Pharmaceuticals (NASDAQ:ALNY) +12%. ImmunityBio  (NASDAQ:IBRX) +6%. Ortho Clinical Diagnostics Holdings  (NASDAQ:OCDX) +5%. Qorvo (NASDAQ:QRVO) +5%. Vanda Pharmaceuticals  (NASDAQ:VNDA) +4%. Losers: COMPASS Pathways P(NASDAQ:CMPS) +-5%. GreenSky (NASD...

Pet pharmacy PetMed Express (PETS) benefited significantly from the pet adoption frenzy and heightened demand for pet care products during the pandemic lockdowns in 2020. However, with the easing of pandemic restrictions, the company is seeing a significant sales decline. And the stock has tu...

The shares of electronic health records company Allscripts Healthcare (MDRX) have generated solid momentum over the past months on the back of earnings and revenue growth across all the company’s business segments in its last reported quarter. So, with increasing demand for healthcare ...

RARITAN, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Further to the joint announcement by Ortho and Quidel Corporation (“ Quidel ”) on December 23, 2021 of the signing of a definitive business combination agreement, Ortho announces that, as a preliminary procedural step in the...

Expects 4Q Reported and Constant Currency Core Revenue Growth of ~4% Fiscal Year Reported and Constant Currency Core Revenue Growth of ~16% and ~15%, respectively RARITAN, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the ...

RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to participate in the 40 th Annual...

Potential deal in the works - Cerner to be acquired by Oracle in mega tech deal. The acquisition of Cerner by Oracle could be a net negative for Oracle shareholders considering how challenging the integration of the company is likely to be. The size of the deal ($28.4 billion incl...